1. Home
  2. CVGI vs FATE Comparison

CVGI vs FATE Comparison

Compare CVGI & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commercial Vehicle Group Inc.

CVGI

Commercial Vehicle Group Inc.

HOLD

Current Price

$3.54

Market Cap

147.9M

ML Signal

HOLD

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$2.79

Market Cap

125.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CVGI
FATE
Founded
2000
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
147.9M
125.6M
IPO Year
2004
2013

Fundamental Metrics

Financial Performance
Metric
CVGI
FATE
Price
$3.54
$2.79
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$4.10
AVG Volume (30 Days)
428.0K
2.2M
Earning Date
05-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
316.18
29.88
EPS
0.04
N/A
Revenue
$755,231,000.00
$6,646,000.00
Revenue This Year
$4.84
N/A
Revenue Next Year
$5.36
N/A
P/E Ratio
$90.75
N/A
Revenue Growth
14.06
N/A
52 Week Low
$1.29
$0.92
52 Week High
$5.88
$3.23

Technical Indicators

Market Signals
Indicator
CVGI
FATE
Relative Strength Index (RSI) 31.28 56.93
Support Level $1.44 $1.01
Resistance Level $3.92 $2.88
Average True Range (ATR) 0.31 0.19
MACD -0.10 0.01
Stochastic Oscillator 2.57 81.75

Price Performance

Historical Comparison
CVGI
FATE

About CVGI Commercial Vehicle Group Inc.

Commercial Vehicle Group Inc and its subsidiaries are a globalised provider of systems, assemblies, and components to international commercial vehicle markets and electric vehicle markets. It delivers real solutions to complex design, engineering, and manufacturing problems while creating positive change for customers, industries, and communities it serves. The company has its manufacturing operations in the United States, Mexico, China, the United Kingdom, the Czech Republic, Ukraine, Morocco, Thailand, India, and Australia. Organisations' products are mainly sold in North America, Europe, and the Asia-Pacific region. It has three segments: Global Seating Segment, Global Electrical systmem, and Trim Systems and Components Segment, with the majority of revenue from Global Seating Segment.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: